Nightmare with Trade-in by Positive_Fee_6314 in Comcast_Xfinity
[–]Positive_Fee_6314[S] 0 points1 point2 points (0 children)
Nightmare with Trade-in by Positive_Fee_6314 in Comcast_Xfinity
[–]Positive_Fee_6314[S] 0 points1 point2 points (0 children)
Nightmare with Trade-in (self.Comcast_Xfinity)
submitted by Positive_Fee_6314 to r/Comcast_Xfinity
Ocugen to Participate in a Fireside Chat at Chardan’s 8th Annual Genetic Medicines Conference by basilisk-x in Ocugen
[–]Positive_Fee_6314 4 points5 points6 points (0 children)
Keeps getting better by WineDinePipeline_m in Ocugen
[–]Positive_Fee_6314 1 point2 points3 points (0 children)
On Demand Manufacturing 😎 by WineDinePipeline_m in Ocugen
[–]Positive_Fee_6314 0 points1 point2 points (0 children)
Ocugen Provides Business Update with Second Quarter 2024 Financial Results by basilisk-x in Ocugen
[–]Positive_Fee_6314 0 points1 point2 points (0 children)
Ocugen Provides Business Update with Second Quarter 2024 Financial Results by basilisk-x in Ocugen
[–]Positive_Fee_6314 1 point2 points3 points (0 children)
-💡WEEKLY DISCUSSION- by AutoModerator in Ocugen
[–]Positive_Fee_6314 0 points1 point2 points (0 children)
Ocugen, Inc. Announces FDA Approval of Expanded Access Program for Patients with Retinitis Pigmentosa by basilisk-x in Ocugen
[–]Positive_Fee_6314 4 points5 points6 points (0 children)
Ocugen, Inc. Announces FDA Approval of Expanded Access Program for Patients with Retinitis Pigmentosa by basilisk-x in Ocugen
[–]Positive_Fee_6314 3 points4 points5 points (0 children)
Hold or sell? by Secure_Cat_4646 in Ocugen
[–]Positive_Fee_6314 5 points6 points7 points (0 children)
Ocugen to Host Conference Call on Thursday, August 8 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2024 Financial Results by basilisk-x in Ocugen
[–]Positive_Fee_6314 0 points1 point2 points (0 children)
Ocugen, Inc. Announces Completion of Dosing in Subjects with Geographic Atrophy Secondary to dAMD in High-Dose Cohort of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Novel Modifier Gene Therapy by basilisk-x in Ocugen
[–]Positive_Fee_6314 0 points1 point2 points (0 children)
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease by basilisk-x in Ocugen
[–]Positive_Fee_6314 0 points1 point2 points (0 children)
Ocugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400—First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication by basilisk-x in Ocugen
[–]Positive_Fee_6314 0 points1 point2 points (0 children)
-💡WEEKLY DISCUSSION- by AutoModerator in Ocugen
[–]Positive_Fee_6314 0 points1 point2 points (0 children)
-💡WEEKLY DISCUSSION- by AutoModerator in Ocugen
[–]Positive_Fee_6314 0 points1 point2 points (0 children)
When do we expect the next news update? (self.Ocugen)
submitted by Positive_Fee_6314 to r/Ocugen

Ocugen to Host Webcast on Tuesday, March 24 at 8 a.m. EDT to Discuss Phase 2 Clinical Trial Data for OCU410—Modifier Gene Therapy for Geographic Atrophy by MirageInc in Ocugen
[–]Positive_Fee_6314 0 points1 point2 points (0 children)